Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
- Analyst Ratings
- About
Zhengye Biotechnology Holding Limited Ordinary Shares (ZYBT)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
06/27/2025: ZYBT (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $0
1 Year Target Price $0
| 0 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -40.38% | Avg. Invested days 16 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 06/27/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 235.36M USD | Price to earnings Ratio 83.17 | 1Y Target Price - |
Price to earnings Ratio 83.17 | 1Y Target Price - | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 3.50 - 14.30 | Updated Date 05/15/2025 |
52 Weeks Range 3.50 - 14.30 | Updated Date 05/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.06 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 10.69% | Operating Margin (TTM) 15.71% |
Management Effectiveness
Return on Assets (TTM) 3.82% | Return on Equity (TTM) 7.15% |
Valuation
Trailing PE 83.17 | Forward PE - | Enterprise Value 246150989 | Price to Sales(TTM) 1.24 |
Enterprise Value 246150989 | Price to Sales(TTM) 1.24 | ||
Enterprise Value to Revenue 9.48 | Enterprise Value to EBITDA 31.36 | Shares Outstanding 47166400 | Shares Floating 4068874 |
Shares Outstanding 47166400 | Shares Floating 4068874 | ||
Percent Insiders 91.64 | Percent Institutions - |
Analyst Ratings
Rating - | Target Price - | Buy - | Strong Buy - |
Buy - | Strong Buy - | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Zhengye Biotechnology Holding Limited Ordinary Shares
Company Overview
History and Background
Due to the absence of specific public information for Zhengye Biotechnology Holding Limited Ordinary Shares, a detailed history and background cannot be provided. Hypothetically, it could be a recently established entity or a private company with limited public data available.
Core Business Areas
- Segment Name 1: Due to the absence of specific public information, it is not possible to describe any segment of Zhengye Biotechnology Holding Limited Ordinary Shares.
Leadership and Structure
Information regarding the leadership team and organizational structure of Zhengye Biotechnology Holding Limited Ordinary Shares is not publicly available.
Top Products and Market Share
Key Offerings
- Product Name 1: Information on top products, market share data, number of users, or revenue generated by Zhengye Biotechnology Holding Limited Ordinary Shares products is not available.
Market Dynamics
Industry Overview
It is impossible to provide an industry overview without knowing the specific industry of the subject company.
Positioning
Without specific information, we cannot assess Zhengye Biotechnology Holding Limited Ordinary Shares's market positioning.
Total Addressable Market (TAM)
Without specific information, we cannot assess Zhengye Biotechnology Holding Limited Ordinary Shares's market positioning or addressable market.
Upturn SWOT Analysis
Strengths
- Information unavailable to provide any specific strength
Weaknesses
- Information unavailable to provide any specific weakness
Opportunities
- Information unavailable to provide any specific opportunity
Threats
- Information unavailable to provide any specific threat
Competitors and Market Share
Key Competitors
Competitive Landscape
A competitive landscape cannot be evaluated due to the lack of competitor information.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is not available.
Future Projections: Future projections are not available.
Recent Initiatives: Information about recent initiatives is not available.
Summary
Insufficient data is available for Zhengye Biotechnology Holding Limited Ordinary Shares to determine its financial strength or areas needing attention. Further research is needed to assess the company's business outlook.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Public web searches and general financial databases. Insufficient public data available for a reliable analysis.
Disclaimers:
The information provided is based on publicly available data and is limited by the lack of information about Zhengye Biotechnology Holding Limited Ordinary Shares. This analysis should not be taken as financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Zhengye Biotechnology Holding Limited Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2025-01-07 | CEO - | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 278 | Website https://www.jlzybio.com |
Full time employees 278 | Website https://www.jlzybio.com | ||
Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. It offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. The company also exports its products to Vietnam, Pakistan, and Egypt. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.